Home » Medical Devices » Pancreatic Fistula Treatment Market

Pancreatic Fistula Treatment Market By Treatment Type (Drugs, Surgical Devices) – Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Summary
Table Of Content

Industry Outlook

The pancreatic fistula treatment market was valued at $1,708 million in 2017 and was expected to grow at a compound annual growth rate (CAGR) of 5.7% from 2018 to 2026. The International Study Group for Pancreatic Fistulas (ISGPF) defines postoperative pancreatic fistula as “an external fistula with a drain output of any measurable volume after postoperative day three and an amylase level greater than three times the upper limit of the normal serum value.” Based on the clinical impact of the fistula on the patient’s hospital stay duration and treatment outcome, pancreatic fistula is categorized into grades A, B, and C. Acute and chronic pancreatitis are the major causative factors for pancreatic fistula (55%), followed by iatrogenic factors such as surgery, percutaneous drainage of pseudocysts, and biopsy (35%), and in rare cases, trauma (10%). Administration of total parenteral nutrition and somatostatin analogs are the common measures used for treating pancreatic fistulas, followed by surgical intervention through ERCP and stenting, indicating the unavailability of an exclusive treatment option (either drug or device) specifically addressing pancreatic fistula. In the future, as the purview of minimally invasive procedures further proliferates, the market may witness the emergence of new avenues.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Synopsis

Higher Adoption of Surgical Techniques for Pancreatic Fistula Treatment to Drive Market Growth

In 2017, the surgical devices segment dominated the market owing to the comparatively higher adoption of medical devices to diagnose and treat pancreatic fistula. In addition, extensive use of sphincterotomies, biliary and pancreatic stents, guidewires, balloons, and cannulae while performing ERCP to manage pancreatic fistula supports the dominance of the ERCP devices segment. The total parenteral nutrition segment dominated the drugs segment, which was attributed to augmented demand for parenteral nutrition products, including single-dose amino acid solutions, carbohydrates, parenteral lipid emulsions, trace elements, vitamins, and minerals as they suppress the production of pancreatic enzymes by restricting the oral intake of food and maintain the nutrition of the patient. Increasing launches of generic drugs and a pipeline of octreotide drugs in clinical trials are expected to support the market growth of the drugs segment in the near future.

Asia-Pacific healthcare infrastructure expansion will drive growth during the forecast period.

In 2017, North America accounted for the largest share of the global pancreatic fistula treatment market due to key driving factors such as the rising prevalence of pancreatic cancer and pancreatic neuroendocrine tumors. With the increasing prevalence of pancreatic fistula, more research studies are being conducted in the region to improve the use of endotherapy and reduce pancreatic fistula complications. High funding for R&D from the U.S. Federal Government, coupled with the presence of major medical device companies in the region, would assist North America in maintaining its pole position during the forecast period. Asia Pacific emerged as the fastest-growing region in the global pancreatic fistula treatment market owing to the growing geriatric population susceptible to pancreatic cancer, adenocarcinomas, pancreatic neuroendocrine tumors, and other gastrointestinal and lifestyle diseases. Growing healthcare infrastructure for efficient and preventive pancreatic surgeries will increase the demand for endoscopic retrograde cholangiopancreatography (ERCP) devices for the management of pre-and postoperative complications related to pancreatic surgeries.

Periods of History and Forecast

2016 : Historic year.

2017: Base Year

2018–2026: Forecast Period

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments was calculated for the forecast period from 2018 to 2026.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Report Scope by Segments

The pancreatic fistula treatment market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on treatment type and geography.

Treatment Type (2016-2026; US$ Million)

Drugs
Octreotide
Total Parental Nutrition (TPN)
Surgical Devices
Fibrin Sealant
Guided Endoscopic Ultrasound (EUS) Devices
Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices
Sphincterotomy
Biliary and pancreatic stents
Accessories (Guidewires, Balloons, and Cannulae)
Surgical Drainage Devices

Geography Segment (2016-2026; millions of dollars)

North America
- U.S.
- Canada
Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

The market is studied in order to understand the current and future market trends in the pancreatic fistula treatment market. The market is estimated by providing the compounded annual growth rate (CAGR) and a data forecast from 2018 to 2026. The product portfolio provided in the report gives information on the drugs and surgical devices used in the treatment of pancreatic fistula. The strategic acquisition, merger, and collaboration among the key players for developing innovative devices are mentioned in the business strategy section. The key players currently engaged in the pancreatic fistula treatment market are Cook Medical, Inc., CONMED Corporation, Fresenius Kabi AG, B. Braun Melsungen AG, Becton Dickinson & Company, Medtronic plc, Novartis AG, and others.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
1.4 Market Segmentation

Chapter 2 Executive Summary
2.1 Introduction
2.2 Global Pancreatic Fistula Treatment Market Portraiture
2.3 Global Pancreatic Fistula Treatment Market, by Treatment Type, 2017 (US$ Mn)
2.4 Global Pancreatic Fistula Treatment Market, by Geography, 2017 (Value US$ Mn)

Chapter 3 Pancreatic Fistula Treatment Products: Market Dynamics and Outlook
3.1 Overview
3.2 Pancreatic Fistula: Treatment Guidelines
3.3 Drivers
3.3.1 High Incidence of Post-operative Pancreatic Fistula
3.3.2 High Clinical and Economical Impact
3.4 Challenges
3.4.1 Limited Efficacy of Current Treatments
3.5 Opportunities
3.5.1 Aggressive Diagnosis and Minimally Invasive Procedures
3.6 Attractive Investment Proposition, by Geography, 2017
3.7 Competitive Landscape
3.7.1 Competitive Landscape, by Key Players, 2017

Chapter 4 Global Pancreatic Fistula Treatment Market, by Treatment Type, 2016–2026 (US$ Mn)
4.1 Overview
4.2 Drugs
4.2.1 Octreotide
4.2.2 Total Parenteral Nutrition (TPN)
4.3 Surgical Devices
4.3.1 Fibrin Sealant
4.3.2 Endoscopic Ultrasound (EUS) Guided Devices
4.3.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices
4.3.3.1 Sphincterotome
4.3.3.2 Biliary & Pancreatic Stents
4.3.3.3 Accessories (Guidewires, Balloons & Cannulae)
4.3.4 Surgical Drainage Devices

Chapter 5 Global Pancreatic Fistula Treatment Market, by Geography, 2016-2026 (US$ Mn)
5.1 Overview
5.2 North America
5.2.1 North America Pancreatic Fistula Treatment Market, by Treatment Type, 2016–2026 (US$ Mn)
5.2.1.1 North America Pancreatic Fistula Treatment Market, by Drug Type, 2016–2026 (US$ Mn)
5.2.1.2 North America Pancreatic Fistula Treatment Market, by Surgical Devices, 2016–2026 (US$ Mn)
5.2.2 North America Pancreatic Fistula Treatment Market, by Country, 2016–2026 (US$ Mn)
5.3 Europe
5.3.1 Europe Pancreatic Fistula Treatment Market, by Treatment Type, 2016–2026 (US$ Mn)
5.3.1.1 Europe Pancreatic Fistula Treatment Market, by Drug Type, 2016–2026 (US$ Mn)
5.3.1.2 Europe Pancreatic Fistula Treatment Market, by Surgical Devices, 2016–2026 (US$ Mn)
5.3.2 Europe Pancreatic Fistula Treatment Market, by Country/Region, 2016–2026 (US$ Mn)
5.4 Asia Pacific
5.4.1 Asia Pacific Pancreatic Fistula Treatment Market, by Treatment Type, 2016–2026 (US$ Mn)
5.4.1.1 Asia Pacific Pancreatic Fistula Treatment Market, by Drug Type, 2016–2026 (US$ Mn)
5.4.1.2 Asia Pacific Pancreatic Fistula Treatment Market, by Surgical Devices, 2016–2026 (US$ Mn)
5.4.2 Asia Pacific Pancreatic Fistula Treatment Market, by Country/Region, 2016–2026 (US$ Mn)
5.5 Latin America
5.5.1 Latin America Pancreatic Fistula Treatment Market, by Treatment Type, 2016–2026 (US$ Mn)
5.5.1.1 Latin America Pancreatic Fistula Treatment Market, by Drug Type, 2016–2026 (US$ Mn)
5.5.1.2 Latin America Pancreatic Fistula Treatment Market, by Surgical Devices, 2016–2026 (US$ Mn)
5.5.2 Latin America Pancreatic Fistula Treatment Market, by Country/Region, 2016–2026 (US$ Mn)
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pancreatic Fistula Treatment Market, by Treatment Type, 2016–2026 (US$ Mn)
5.6.1.1 Middle East & Africa Pancreatic Fistula Treatment Market, by Drug Type, 2016–2026 (US$ Mn)
5.6.1.2 Middle East & Africa Pancreatic Fistula Treatment Market, by Surgical Devices, 2016–2026 (US$ Mn)
5.6.2 Middle East & Africa Pancreatic Fistula Treatment Market, by Region, 2016–2026 (US$ Mn)

Chapter 6 Company Profiles
6.1 Cook Medical, Inc.
6.2 Endo-Flex GmbH
6.3 CONMED Corporation
6.4 Fresenius Kabi AG
6.5 B. Braun Melsungen AG
6.6 Becton, Dickinson and Company
6.7 Medtronic plc
6.8 Olympus Corporation
6.9 Novartis AG
6.10 Baxter International, Inc.
6.11 Ethicon USA, LLC

List of Figures

FIG. 1 Global Pancreatic Fistula Treatment Market: Research Methodology
FIG. 2 Pancreatic Fistula Treatment: Market Segmentation
FIG. 3 Global Pancreatic Fistula Treatment Market, by Treatment Type, 2017 (US$ Mn)
FIG. 4 Global Pancreatic Fistula Treatment Market, by Geography, 2017 (Value US$ Mn)
FIG. 5 Attractive Investment Proposition: Global Pancreatic Fistula Treatment Market, by Geography, 2017
FIG. 6 Competitive Landscape, by Key Players, 2017
FIG. 7 Global Octreotide Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)
FIG. 8 Global Total Parenteral Nutrition (TPN) Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)
FIG. 9 Global Fibrin Sealant Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)
FIG. 10 Global Endoscopic Ultrasound (EUS) Guided Devices Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)
FIG. 11 Global Sphincterotome Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)
FIG. 12 Global Biliary & Pancreatic Stents Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)
FIG. 13 Global Accessories Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)
FIG. 14 Global Surgical Drainage Devices Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)

List of Tables

TABLE 1 Global Pancreatic Fistula Treatment Market, by Treatment Type, 2016–2026 (US$ Mn)
TABLE 2 Global Drugs Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)
TABLE 3 Global Surgical Devices Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)
TABLE 4 Global ERCP Devices Market for Pancreatic Fistula Treatment, 2016–2026 (US$ Mn)
TABLE 5 Global Pancreatic Fistula Treatment Market, by Geography, 2016–2026 (US$ Mn)
TABLE 6 North America Pancreatic Fistula Treatment Products Market, by Treatment Type, 2018–2026 (US$ Mn)
TABLE 7 North America Pancreatic Fistula Treatment Products Market, by Drug Type, 2018–2026 (US$ Mn)
TABLE 8 North America Pancreatic Fistula Treatment Products Market, by Surgical Devices, 2018–2026 (US$ Mn)
TABLE 9 North America Pancreatic Fistula Treatment Market, by Country, 2016–2026 (US$ Mn)
TABLE 10 Europe Pancreatic Fistula Treatment Products Market, by Treatment Type, 2018–2026 (US$ Mn)
TABLE 11 Europe Pancreatic Fistula Treatment Products Market, by Drug Type, 2018–2026 (US$ Mn)
TABLE 12 Europe Pancreatic Fistula Treatment Products Market, by Surgical Devices, 2018–2026 (US$ Mn)
TABLE 13 Europe Pancreatic Fistula Treatment Market, by Country/Region 2016–2026 (US$ Mn)
TABLE 14 Asia Pacific Pancreatic Fistula Treatment Products Market, by Treatment Type, 2018–2026 (US$ Mn)
TABLE 15 Asia Pacific Pancreatic Fistula Treatment Products Market, by Drug Type, 2018–2026 (US$ Mn)
TABLE 16 Asia Pacific Pancreatic Fistula Treatment Products Market, by Surgical Devices, 2018–2026 (US$ Mn)
TABLE 17 Asia Pacific Pancreatic Fistula Treatment Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 18 Latin America Pancreatic Fistula Treatment Products Market, by Treatment Type, 2018–2026 (US$ Mn)
TABLE 19 Latin America Pancreatic Fistula Treatment Products Market, by Drug Type, 2018–2026 (US$ Mn)
TABLE 20 Latin America Pancreatic Fistula Treatment Products Market, by Surgical Devices, 2018–2026 (US$ Mn)
TABLE 21 Latin America Pancreatic Fistula Treatment Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 22 Middle East & Africa Pancreatic Fistula Treatment Products Market, by Treatment Type, 2018–2026 (US$ Mn)
TABLE 23 Middle East & Africa Pancreatic Fistula Treatment Products Market, by Drug Type, 2018–2026 (US$ Mn)
TABLE 24 Middle East & Africa Pancreatic Fistula Treatment Products Market, by Surgical Devices, 2018–2026 (US$ Mn)
TABLE 25 Middle East & Africa Pancreatic Fistula Treatment Market, by Region, 2016–2026 (US$ Mn)
TABLE 26 Cook Medical, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Development)
TABLE 27 Endo-Flex GmbH: Company Snapshot (Company Overview; Product Portfolio; Business Description/Key Development)
TABLE 28 CONMED Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Development)
TABLE 29 Fresenius Kabi AG: Company Snapshot (Company Overview; Product Portfolio; Business Description/Key Development)
TABLE 30 B. Braun Melsungen AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Development)
TABLE 31 Becton, Dickinson and Company: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Development)
TABLE 32 Medtronic plc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Development)
TABLE 33 Olympus Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Development)
TABLE 34 Novartis AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Development)
TABLE 35 Baxter International, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Development)
TABLE 36 Ethicon USA, LLC: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Business Description/Key Development)

Frequently Asked Questions:

What is the size of Pancreatic Fistula Treatment Market?

The market for Pancreatic Fistula Treatment Market is expected to reach US$ 1,708.6 Mn by 2026.

What is the Pancreatic Fistula Treatment Market CAGR?

The Pancreatic Fistula Treatment Market is expected to see significant CAGR growth over the coming years, at 5.7%.

What is the Forecast period considered for Pancreatic Fistula Treatment Market?

The report is forecasted from 2018-2026.

What is the base year considered for Pancreatic Fistula Treatment Market?

The base year of this report is 2017.

Who are the major players in this market?

Cook Medical, Inc., CONMED Corporation, Fresenius Kabi AG, B. Braun Melsungen AG, Becton Dickinson & Company, Medtronic plc, Novartis AG are some of the major players in the global market.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –